Founded in June 2014, AIDOT's Cerviray AI is an artificial intelligence-based cervical cancer remote reading system. Cerviray AI is equipped with AIDOT-NETv1, an AI algorithm developed with AIDOT's own technology, and the system was developed through joint research with two of the best hospitals in Korea, Seoul National University Bundang Hospital and Anam Korea University Hospital.
Over the past year, AIDOT has collaborated with large hospitals, examination centers, and various companies that provide medical facilities in China, and all of the joint companies have judged that AIDOT products are sufficient to enter the Chinese market. Currently, AIDOT is further considering various methods to deploy products to hospitals directly under the health authorities, secondary and tertiary large hospitals, and examination centers.
AIDOT established a subsidiary in Beijing, China in 2017, and a joint venture in Shenzhen in 2020. In addition to Cerviray AI products, AIDOT includes a 'Sonodot AI system' based on carotid ultrasound, a stroke pre-diagnosis device 'Naodot AI system', and a 'Gigadot AI system' that enables real-time diagnosis of digestive system. In addition, AIDOT is currently developing an AI system that diagnoses chronic alcoholic liver disease.
2021-11-30 / NEWSPIM / 주옥함 기자